Return to healthandage.com Presentations IndexEAMA Home Page

EAMA IV - September 2001 - VERY OLD PATIENT CENTERED MEDICINE: Assessment and management of geriatric syndromes

Immunosenescence and Vaccination in the Elderly
Author: Pr Beatrix Grubeck-Loebenstein, Innsbruck (A), Slides comments: Dr Ruediger Buschfort, Oslberg (D)

First Previous

Slide 16 of 16

    The percentage of elderly persons without protective antibodies following vaccination against tick-borne encephalitis is already relatively high in the first year after vaccination. It increases steadily afterwards. In contrast, in the young group almost everybody is protected for a period of at least 6 years following vaccination.
    From these data one can conclude that new vaccination strategies for the elderly will have to be introduced. Shorter vaccination intervals should be considered and antibody titers checked frequently. The pharmaceutical industry will have to concentrate on developing new vaccines specifically designed to fulfill the needs of the aging immune system.



Return to healthandage.com Presentations IndexEAMA Home Page


Suggest EAMA Email This Presentation to a Colleague.

To have Healthandage.com email the Web address (URL) of this presentation to a colleague, fill out the form and click the "Suggest Now!" button.

Enter your colleague's e-mail:


Enter your name:


This is your opportunity to give feedback or ideas about how we can improve this area!

Enter your e-mail address:

Enter your comments here:

Do you find this section:
Very useful    Moderately useful    Not at all useful


Please send me the HealthandAge.com bimonthly newsletter



Copyright © . All rights reserved.
[Privacy Policy | Terms of use | About Us ]